APA

Thankamony A., Tossavainen P. H., Sleigh A., Acerini C., Elleri D., Dalton R. N., Jackson N. C., Umpleby A. M., Williams R. M. & Dunger D. B. (20140408). Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes. : The Journal of clinical endocrinology and metabolism.

Chicago

Thankamony A, Tossavainen P H, Sleigh A, Acerini C, Elleri D, Dalton R N, Jackson N C, Umpleby A M, Williams R M and Dunger D B. 20140408. Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes. : The Journal of clinical endocrinology and metabolism.

Harvard

Thankamony A., Tossavainen P. H., Sleigh A., Acerini C., Elleri D., Dalton R. N., Jackson N. C., Umpleby A. M., Williams R. M. and Dunger D. B. (20140408). Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes. : The Journal of clinical endocrinology and metabolism.

MLA

Thankamony A, Tossavainen P H, Sleigh A, Acerini C, Elleri D, Dalton R N, Jackson N C, Umpleby A M, Williams R M and Dunger D B. Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes. : The Journal of clinical endocrinology and metabolism. 20140408.